Automated description from the Alliance of Genome Resources (Release 5.1.1)
Predicted to enable bHLH transcription factor binding activity; protein C-terminus binding activity; and transcription coactivator activity. Predicted to be involved in several processes, including proteasome regulatory particle assembly; regulation of insulin secretion; and type B pancreatic cell apoptotic process. Predicted to be part of proteasome regulatory particle, base subcomplex. Predicted to be active in cytoplasm and nucleus. Is expressed in exoccipital bone; nasal pit; orbito-sphenoid; otocyst; and temporal bone petrous part. Orthologous to human PSMD9 (proteasome 26S subunit, non-ATPase 9).